Published online Jun 28, 2017. doi: 10.4329/wjr.v9.i6.269
Peer-review started: February 6, 2017
First decision: March 7, 2017
Revised: March 21, 2017
Accepted: April 18, 2017
Article in press: April 19, 2017
Published online: June 28, 2017
Processing time: 140 Days and 6.8 Hours
The Tumor, Node, Metastasis (TNM) staging system, adopted by the Union for International Cancer Control (UICC) and the American Joint Committee on Cancer (AJCC), has been recently revised, with the new 8th edition of the staging manual being published in January 2017. This edition has few but important evidence-based changes to the TNM staging system used for lung cancer. Radiologists should be aware of the updated classification system to accurately provide staging information to oncologists and oncosurgeons. In this article, we discuss the rationale, illustrate the changes with relevance to Radiology, and review the clinical implications of the 8th edition of the UICC/AJCC TNM staging system with regards to lung cancer.
Core tip: This article discusses the rationale, illustrates the changes with relevance to Radiology, and reviews the clinical implications of the 8th edition of the Union for International Cancer Control/American Joint Committee on Cancer Tumor, Node, Metastasis staging of lung cancer.
